A Mobile Gaming App to Improve Adherence to PrEP (NCT05762705)
A Multisite Randomized Trial of Viral Combat: A Mobile Gaming App to Improve Adherence to PrEP
🩺 Plain-English Summary (8th-Grade Level)
In this study, the investigators will test the mobile game, Viral Combat, for efficacy and acceptability among diverse participants, ages 15-34 years, receiving PrEP care in clinical settings in New England and Mississippi. Formative evaluation interviews will be conducted with stakeholders (healthcare workers, clinic administrators, and patients taking PrEP) to inform intervention delivery. Data from the formative interviews will also be used to make necessary adaptations to the game and assess acceptability for diverse populations and clinics. Viral Combat will then be further tested with 200 participants ages 15-34 years, receiving PrEP care at clinical sites in the South (n=100 Jackson, MS) and New England (n=100, Providence, RI; Boston, MA) in a multisite Hybrid Type 1 effectiveness-implementation randomized controlled trial (RCT). This trial will test the efficacy of the intervention compared to a control condition (a non-PrEP related game) on biological and behavioral measures. At the end of the trial, a summative evaluation of the implementation context using the i-PARIHS framework will occur. These interviews with study participants and clinic staff will inform future implementation and dissemination of Viral Combat.
Who can join: Review the eligibility criteria below.
Location: Boston Medical Center — Boston, Massachusetts
Age range: 15 Years to 34 Years
🧪 Interventions in This Study
- Multilevel Gaming Adherence Intervention (BEHAVIORAL)
- Treatment as Usual + (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Boston Medical Center — Boston, Massachusetts
- University of Mississippi Medical Center — Jackson, Mississippi
- Lifespan (The Miriam Hospital and Rhode Island Hospital) — Providence, Rhode Island
📞 Contact the Study Coordinator
Phone: (401) 455-6375
Email: laura_whiteley@brown.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Medication Adherence
- My Interprofessional Care Team for Adherence and Research Engagement Disparities — Springfield, Massachusetts
- Medication Adherence in Patients With Sarcoidosis — Baltimore, Maryland
- MITIGAAT: Multifaceted Intervention To Improve Graft Outcome Disparities in African American Kidney Transplants — Charleston, South Carolina
- Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda — Boston, Massachusetts
- Adaptive Cell Phone Support (ACPS) — Los Angeles, California
Explore by condition: All Medication Adherence clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.